Clinical Trial Update: The Study of Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial investigating a treatment for metastatic pancreatic adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED